King Pharmaceuticals, Inc. (Nasdaq:KG)(Was KING)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
King Pharmaceuticals, Inc. (Nasdaq:KG)(Was KING)

An SI Board Since June 1998

Posts	SubjectMarks	Bans	Symbol
61	3	0	KG

Emcee: Randi	Type: Unmoderated

Min Hr Day Wk Mon Yr 3 Yr Log

Introduction Market Data Compact

KG 21.27

-9.6%

Oct 30 3:56 PM EDT

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
61	What is the take of King shareholders - or those who follow KG - with respect to	Harold Engstrom	-	5/8/2003
60	Patent issues, some revenue questions. Check out SEC filings.	The Philosopher	-	4/16/2003
59	Thanks, guys. I've looked a little closer and have decided to pass on the	Paul Senior	-	4/16/2003
58	Management, revenue, issues raised in SEC filings. See SB downgrade today.	Sr K	-	4/16/2003
57	May I ask what some of those unresolved issues are to which you are referring?	Paul Senior	-	4/16/2003
56	I liked the stock on the fundamentals, but when I looked it at about six months	The Philosopher	-	4/16/2003
55	I liked the stock on the fundamentals, but when I looked it at about six months	The Philosopher	-	4/16/2003
54	I'm looking for an opinion on KG. I don't know KG's product line or	Paul Senior	-	4/15/2003
53	I agree that cash generation is key. They don't say cash is king for nothin	The Philosopher	-	2/4/2003
52	My average cost is $15.42, net of 2 cycles of covered calls. So I'm actually	Sr K	-	2/4/2003
51	You can't be happy with the past few months, but I can't see any reason	The Philosopher	-	2/3/2003
50	I like it and I'm in.	Sr K	-	2/3/2003
49	This thread seems moribund -- anybody still following it? I came across King in	The Philosopher	-	2/3/2003
48	KG annual meeting very positive---steady climb from here as Altace sales take of	Maven1	-	6/30/2002
47	07:43 ET King Pharms (KG) 37.99: Goldman Sachs upgrades to REC LIST from Mkt Out	Jim Oravetz	-	11/16/2001
46	Friday June 1, 7:30 am Eastern Time Press Release SOURCE: King Pharmaceuticals,	betone	-	6/1/2001
45	I still follow it, but sold it by allowing a 40 call to take it away. My 4th tim	Sr K	-	3/7/2001
44	Jay: I'm sorry I do not follow this one now..Gregor	gregor	1	3/7/2001
43	Anyone still following King? It appears that Altace is growing nicely with acce	radman33	-	3/7/2001
42	OT The real reason? Because MCI repeatedly slammed to take customers, and ov	Sr K	-	11/6/2000
41	Am very happy! Sometimes we get a break! This is in my IRA and I plan to keep	babette spatz	-	11/5/2000
40	Just posting to comment that the move to new KG highs this week also took out th	Sr K	-	11/5/2000
39	Also, S&P started rating KG with **** in October and the next day raised it	babette spatz	-	10/8/2000
38	Positive news from FDA on Altace on Thursday, followed by upgrades Friday from G	Sr K	-	10/8/2000
37	Not much news out, except regarding flu shots. Sounds like "the same old,	babette spatz	-	9/29/2000

Go to reply# or date (mm/dd/yy):